Welcome to CDC stacks |

Welcome to CDC stacks |

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

information icon

information icon

information icon

Clear All Simple Search

Advanced Search

delete_icon

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Protecting a new generation against HPV: Are we willing to be bold?

Published Date:

Oct 30 2014

Publisher's site:

http://dx.doi.org/10.4161/21645515.2014.970068 New Site Icon

Source:

Hum Vaccin Immunother. 10(9):2559-2561.

[PDF-59.84 KB]

Details:

Alternative Title:

Hum Vaccin Immunother

Personal Author:

Vanderpool, Robin C. ; Crosby, Richard A. ; Stradtman, Lindsay R. ;

Description:

Despite the advent of a novel human papillomavirus (HPV) vaccine to prevent associated cancers, HPV vaccination rates in the United States (US) remain well below national goals. Two recent reports by the Centers for Disease Control and Prevention (CDC) and the President's Cancer Panel (PCP) have identified missed clinical opportunities as an intervention point for increasing HPV vaccination rates, including the provision of immunization in alternative venues by varying healthcare providers. In this paper, we specifically comment on the idea of offering HPV vaccination in emergency departments (ED) by emergency medicine (EM) physicians as posited by Hill and Okugo (2014), identifying both strengths and limitations to this strategy. We also offer ideas for additional research, suggest provider and healthcare systems changes, and discuss needed policy changes to improve HPV vaccination rates in the US.

Subject:

[+]

Pubmed ID:

25483474

Pubmed Central ID:

PMC4772861

Document Type:

Journal Article

Funding:

U48 DP001932/DP/NCCDPHP CDC HHS/United States

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

nihms760910.nxml

application/octet-stream

No Related Documents.

You May Also Like:

Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017

Personal Author:

Aguado, M. Teresa; Barratt, Jane; Beard, John R.; Blomberg, Bonnie B.; Chen, Wilbur H.; Hickling, Julian; Hyde, Terri B.; Jit, Mark; Jones, Rebecca; Poland, Gregory A.; Friede, Martin; Ortiz, Justin R.;

Published Date:

Jan 12 2018

Source:

Vaccine. 36(7):921-931.

Description:

Many industrialized countries have implemented routine immunization policies for older adults, but similar strategies have not been widely implemented in low- and middle-income countries (LMICs). In March 2017, the World Health Organization (WHO) con...

File Type:

[PDF - 120.11 KB]
Advisory Committee on Immunization Practices record of the proceedings : October 24-25, 2007, Atlanta, Georgia

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2017 October 24-25 : Atlanta, GA)

Published Date:

2007

Series:

ACIP meeting Minutes

Description:

min-2007-10-508.pdf

File Type:

[PDF - 663.19 KB]
Preparing for the availability of a partially effective HIV vaccine: Some lessons from other licensed vaccines

Personal Author:

Chen, Robert T.; Hu, Dale J.; Dunne, Eileen; Shaw, Michael; Mullins, Jim; Rerks-Ngarm, Supachai;

Published Date:

Jul 13 2011

Source:

Vaccine. 29(36):6072-6078.

File Type:

[PDF - 133.28 KB]
A Vaccine Against Cervical Cancer: Context for the Global Public Health Practitioner

Personal Author:

Jennings, Mary Carol; Loharikar, Anagha;

Published Date:

December 27 2018

Source:

Glob Health Sci Pract. 2018; 6(4):629-634

File Type:

[PDF - 215.68 KB]
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models

Personal Author:

Brisson, Marc; Bénard, Élodie; Drolet, Mélanie; Bogaards, Johannes A; Baussano, Iacopo; Vänskä, Simopekka; Jit, Mark; Boily, Marie-Claude; Smith, Megan A; Berkhof, Johannes; Canfell, Karen; Chesson, Harrell W; Burger, Emily A; Choi, Yoon H; De Blasio, Birgitte Freiesleben; De Vlas, Sake J; Guzzetta, Giorgio; Hontelez, Jan A C; Horn, Johannes; Jepsen, Martin R; Kim, Jane J; Lazzarato, Fulvio; Matthijsse, Suzette M; Mikolajczyk, Rafael; Pavelyev, Andrew; Pillsbury, Matthew; Shafer, Leigh Anne; Tully, Stephen P; Turner, Hugo C; Usher, Cara; Walsh, Cathal;

Published Date:

September 27 2016

Source:

Lancet Public Health. 1(1):e8-e17

Description:

BackgroundModelling studies have been widely used to inform human papillomavirus (HPV) vaccination policy decisions; however, many models exist and it is not known whether they produce consistent predictions of population-level effectiveness and herd...

File Type:

[PDF - 892.82 KB]